Page last updated: 2024-08-24

glucose, (beta-d)-isomer and Berger Disease

glucose, (beta-d)-isomer has been researched along with Berger Disease in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's1 (25.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chen, HC; Fukui, M; Koide, H; Tomino, Y; Watanabe, A; Yaguchi, Y; Yokoyama, K1
Barratt, J; Floege, J1
Chen, C; Gan, L; Li, X; Luo, H; Zhou, Q; Zhu, M1
Hasegawa, Y; Hattori, T; Inagaki, Y; Koseki, J; Sadakane, C; Shindo, S; Takeda, H; Takeda, S1

Trials

1 trial(s) available for glucose, (beta-d)-isomer and Berger Disease

ArticleYear
Acteoside relieves mesangial cell injury by regulating Th22 cell chemotaxis and proliferation in IgA nephropathy.
    Renal failure, 2018, Volume: 40, Issue:1

    Topics: Adult; Biopsy; Cell Line; Cell Proliferation; Chemokine CCL20; Chemokine CCL22; Chemokine CCL27; Chemotaxis; Coculture Techniques; Disease Progression; Drug Therapy, Combination; Female; Glomerulonephritis, IGA; Glucosides; Humans; Immunosuppressive Agents; Male; Mesangial Cells; Middle Aged; Phenols; Proteinuria; Rehmannia; T-Lymphocytes, Helper-Inducer; Transforming Growth Factor beta1; Treatment Outcome; Valsartan; Young Adult

2018

Other Studies

3 other study(ies) available for glucose, (beta-d)-isomer and Berger Disease

ArticleYear
Oxidative metabolism of polymorphonuclear leukocytes (PMN) in patients with IgA nephropathy.
    Journal of clinical laboratory analysis, 1992, Volume: 6, Issue:1

    Topics: Adult; Female; Glomerulonephritis, IGA; Humans; Hydrogen Peroxide; Immunoglobulin G; In Vitro Techniques; Kidney Glomerulus; Male; Middle Aged; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Tetradecanoylphorbol Acetate; Zymosan

1992
SGLT-2 inhibition in IgA nephropathy: the new standard of care?
    Kidney international, 2021, Volume: 100, Issue:1

    Topics: Benzhydryl Compounds; Glomerulonephritis, IGA; Glucosides; Humans; Immunosuppressive Agents; Kidney; Renal Insufficiency, Chronic; Standard of Care

2021
TJN-259 improves mesangial lesions in experimental immunoglobulin A nephropathy in ddY mice.
    Biological & pharmaceutical bulletin, 2009, Volume: 32, Issue:10

    Topics: Animals; Anti-Inflammatory Agents; Cattle; Collagen Type IV; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Glomerular Mesangium; Glomerulonephritis, IGA; Glucosides; Immunoglobulin A; Kidney; Male; Mice; Mice, Inbred Strains; Phenols; Plant Extracts; Pyridines; Sclerosis; Serum Albumin; Stachys; Transforming Growth Factor beta1

2009